Literature DB >> 30198334

Biogenic synthesis of silver nanoparticles using extracts of Leptolyngbya JSC-1 that induce apoptosis in HeLa cell line and exterminate pathogenic bacteria.

Shah Zada1, Aftab Ahmad1, Sikandar Khan1, Xinlu Yu1, Kun Chang1, Arshad Iqbal2, Adnan Ahmad3, Sadeeq Ullah1, Muslim Raza1, Ajmal Khan1, Shahbaz Ahmad1, Pengcheng Fu1,4.   

Abstract

Utilizing novel approaches for the green synthesis of metal nanoparticles are of great importance. Therefore, we reported biogenic synthesis of silver nanoparticles (AgNPs) using extracts of Leptolyngbya strain JSC-1, and their significant applications against pathogenic bacteria and cancerous HeLa cell line. The biofabricated AgNPs were characterized by UV-visible spectroscopy, FTIR, SEM, TEM, DLS and zeta-potential. The as prepared AgNPs were assessed for inhibition of bacterial growth and induction of apoptosis in HeLa cells by different doses of AgNPs was evaluated. UV-visible spectroscopy and FTIR of AgNPs demonstrated the surface plasmon resonance at 413 nm and interaction among extract and nanoparticles, respectively. Electron microscopy revealed the morphology and DLS demonstrated size distribution of the particles (10-100 nm). Zeta potential values were between -47 and 0 mV, indicating stability of the particles. Proliferation of HeLa cells was significantly inhibited and severe cytotoxicity with higher intracellular uptake were observed after applying high concentration of AgNPs. Efficient inhibition zones (17 ± 2 and 21 ± 2 mm) were produced at maximum concentration (100 µl from 1 mg ml-1 stock of AgNPs) for Staphylococcus aureus and Escherichia coli, respectively. These findings reveal that the biofabricated AgNPs possess strong antibacterial activity and ability to induce apoptosis in cancer cell line (HeLa).

Entities:  

Keywords:  HeLa; Silver nanoparticles; antibacterial; anticancer; nanotechnology

Mesh:

Substances:

Year:  2018        PMID: 30198334     DOI: 10.1080/21691401.2018.1499663

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  6 in total

1.  Enhanced survival of Lacticaseibacillus rhamnosus in simulated gastrointestinal conditions using layer-by-layer encapsulation.

Authors:  Afsaneh Chehreara; Fatemeh Tabandeh; Maryam Otadi; Afshar Alihosseini; Ali Partovinia
Journal:  Biotechnol Lett       Date:  2022-09-24       Impact factor: 2.716

Review 2.  Microbial Nano-Factories: Synthesis and Biomedical Applications.

Authors:  Shubhrima Ghosh; Razi Ahmad; Md Zeyaullah; Sunil Kumar Khare
Journal:  Front Chem       Date:  2021-04-16       Impact factor: 5.221

3.  Green Synthesis and Characterization of Silver Nanoparticles with High Antibacterial Activity Using Cell Extracts of Cyanobacterium Pseudanabaena/Limnothrix sp.

Authors:  Dimitra Karageorgou; Panagiota Zygouri; Theofylaktos Tsakiridis; Mohamed Amen Hammami; Nikolaos Chalmpes; Mohammed Subrati; Ioannis Sainis; Konstantinos Spyrou; Petros Katapodis; Dimitrios Gournis; Haralambos Stamatis
Journal:  Nanomaterials (Basel)       Date:  2022-07-04       Impact factor: 5.719

4.  Biogenic synthesis of silver nanoparticles using cyanobacterium Leptolyngbya sp. WUC 59 cell-free extract and their effects on bacterial growth and seed germination.

Authors:  Yadvinder Singh; Sandeep Kaushal; Ramandeep Singh Sodhi
Journal:  Nanoscale Adv       Date:  2020-07-30

Review 5.  Chiral nanomaterials for tumor therapy: autophagy, apoptosis, and photothermal ablation.

Authors:  Zaihui Peng; Long Yuan; Juncheng XuHong; Hao Tian; Yi Zhang; Jun Deng; Xiaowei Qi
Journal:  J Nanobiotechnology       Date:  2021-07-22       Impact factor: 10.435

Review 6.  Synthesis, Characterization and Biomedical Application of Silver Nanoparticles.

Authors:  Ashwini Naganthran; Gayathiri Verasoundarapandian; Farah Eryssa Khalid; Mas Jaffri Masarudin; Azham Zulkharnain; Norazah Mohammad Nawawi; Murni Karim; Che Azurahanim Che Abdullah; Siti Aqlima Ahmad
Journal:  Materials (Basel)       Date:  2022-01-06       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.